BACKGROUND
Neck rejuvenation has consistently ranked among the most sought-after cosmetic treatments. This area of the body presents a confluence of aging-related concerns, including skin deterioration, weakened ligaments, displacement of adipose tissue, increased platysma tension, and alterations in the jawline due to bone changes. In instances where a more extensive surgical intervention becomes necessary to restore tissue positioning and address excess skin and fat, surgical procedures are typically recommended for critical cases. However, for individuals who either don't meet the criteria for surgery or opt against it, alternative approaches involving injection techniques offer the opportunity to target and address the various facets of the aging process in the neck region.
INTRODUCTION
Our protocol investigates neck rejuvenation using injectable treatments, namely ABO Botulinum Toxin A solution (Alluzience, Ipsen Ltd, Slough, UK/Galderma SA, Lausanne, Switzerland) and NASHA (non-animal hyaluronic acid) gel 12 mg/ml as a skin booster. (Restylane Skinboosters, Vital Light lidocaine, QMED AB/Galderma, Uppsala, Sweden). Cases characterized by significant skin laxity or pronounced subcutaneous fat accumulation in the submental region are deemed ineligible for this specific treatment approach.
The utilization of Abobotulinum Toxin A solution has gained prominence as a noteworthy therapeutic approach for its ability to interrupt muscle hypertonicity and modulate muscle contraction, obtaining an aesthetic improvement resulting from muscle relaxation. Each vial of the solution contains 125
This protocol is primarily intended for patients who exhibit concurrent skin degeneration and hypertonicity of the platysma and depressor muscles within the lower third of the face. Ideally, the most suitable candidates for this treatment are individuals for whom the predominant components of aging are muscle hypertonicity and skin degeneration.
The utilization of Abobotulinum Toxin A solution has gained prominence as a noteworthy therapeutic approach for its ability to interrupt muscle hypertonicity and modulate muscle contraction, obtaining an aesthetic improvement resulting from muscle relaxation. Each vial of the solution contains 125